ThromboGenics planning private placement

ThromboGenics N.V. (Euronext:THR) plans to raise about EUR 35 million ($46.4 million) through the sale of up to 2.9 million shares in a private placement. KBC; Jefferies; and Petercam are joint bookrunners. KBC is also global coordinator. ...